Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.

Gielen, Evelien; Aldvén, Martina; Kanis, John A; Borgström, Fredrik; Senior, Emmanuelle; Willems, Damon

Gielen, Evelien; Aldvén, Martina; Kanis, John A; Borgström, Fredrik; Senior, Emmanuelle; Willems, Damon.

Affiliation

Gielen E; Department of Geriatrics, UZ Leuven, Louvain, Belgium.
Aldvén M; Geriatrics & Gerontology, Department of Public Health and Primary Care, KU Leuven, Louvain, Belgium.
Kanis JA; Quantify Research, Stockholm, Sweden.
Borgström F; University of Sheffield, Sheffield, UK.
Senior E; Mary MacKillop Health Institute, Catholic University of Australia, Melbourne, Australia.
Willems D; Quantify Research, Stockholm, Sweden.

Osteoporos Int ; 35(7): 1173-1183, 2024 Jul.

Article in En | MEDLINE | ID: mdl-38565690

Subject(s)

Alendronate; Antibodies, Monoclonal; Bone Density Conservation Agents; Cost-Benefit Analysis; Drug Costs; Markov Chains; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality-Adjusted Life Years; Teriparatide; Humans; Female; Osteoporotic Fractures/prevention & control; Osteoporotic Fractures/economics; Osteoporotic Fractures/epidemiology; Bone Density Conservation Agents/therapeutic use; Bone Density Conservation Agents/economics; Belgium/epidemiology; Osteoporosis, Postmenopausal/drug therapy; Osteoporosis, Postmenopausal/economics; Osteoporosis, Postmenopausal/complications; Alendronate/therapeutic use; Alendronate/economics; Alendronate/administration & dosage; Teriparatide/therapeutic use; Teriparatide/economics; Teriparatide/administration & dosage; Aged; Drug Costs/statistics & numerical data; Antibodies, Monoclonal/economics; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal/administration & dosage; Drug Therapy, Combination; Middle Aged; Drug Administration Schedule; Drug Substitution/economics; Drug Substitution/statistics & numerical data

Key words

Cost-effectiveness; Economic evaluation; Imminent fracture risk; Markov-microsimulation model; Osteoporosis; Recent fracture

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Markov Chains / Drug Costs / Cost-Benefit Analysis / Quality-Adjusted Life Years / Alendronate / Teriparatide / Bone Density Conservation Agents / Osteoporotic Fractures / Antibodies, Monoclonal Limits: Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2024 Type: Article Affiliation country: Belgium

Fulltext

XML

PubMed Links

Search on Google